- Home
- CRDL vs IH Comparison
CRDL vs IH Comparison
Compare CRDL & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- IH
- Stock Information
- Founded
- CRDL 2017
- IH 1996
- Country
- CRDL Canada
- IH China
- Employees
- CRDL N/A
- IH N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- IH Other Consumer Services
- Sector
- CRDL Health Care
- IH Real Estate
- Exchange
- CRDL Nasdaq
- IH Nasdaq
- Market Cap
- CRDL 80.1M
- IH 94.2M
- IPO Year
- CRDL N/A
- IH 2020
- Fundamental
- Price
- CRDL $1.15
- IH $2.32
- Analyst Decision
- CRDL Strong Buy
- IH
- Analyst Count
- CRDL 3
- IH 0
- Target Price
- CRDL $9.00
- IH N/A
- AVG Volume (30 Days)
- CRDL 150.5K
- IH 12.1K
- Earning Date
- CRDL 05-20-2025
- IH 06-27-2025
- Dividend Yield
- CRDL N/A
- IH 3.67%
- EPS Growth
- CRDL N/A
- IH N/A
- EPS
- CRDL N/A
- IH 0.25
- Revenue
- CRDL N/A
- IH $126,344,481.00
- Revenue This Year
- CRDL N/A
- IH $39.02
- Revenue Next Year
- CRDL N/A
- IH N/A
- P/E Ratio
- CRDL N/A
- IH $9.81
- Revenue Growth
- CRDL N/A
- IH N/A
- 52 Week Low
- CRDL $0.77
- IH $1.47
- 52 Week High
- CRDL $3.12
- IH $3.18
- Technical
- Relative Strength Index (RSI)
- CRDL 57.19
- IH 56.48
- Support Level
- CRDL $1.02
- IH $2.20
- Resistance Level
- CRDL $1.19
- IH $2.45
- Average True Range (ATR)
- CRDL 0.07
- IH 0.13
- MACD
- CRDL 0.01
- IH 0.03
- Stochastic Oscillator
- CRDL 73.53
- IH 72.92
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. The majority of iHuman Inc's revenue comes from mainland China.